ClinicalTrials.gg
Sign In

Epistaxis clinical trials

The registry lists 96 studies for Epistaxis across more than 10 countries. 22 are recruiting or about to start. 60 of them are mainly about Epistaxis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Epistaxis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
50
Not yet recruiting
12
Status unknown
12
Recruiting
10
Terminated
7
Withdrawn
3

Phase

Phase 2
21
Phase 4
11
Phase 3
10
Phase 1
8
Early Phase 1
1

Where

United States
22
France
13
Canada
10
Turkey
8
Egypt
5
Switzerland
4

Who runs them

Assiut University (6) · University of Zurich (3) · Cure HHT (3) · Bezmialem Vakif University (3) · Buddhist Tzu Chi General Hospital (2) · University of California, San Diego (2) · Ajou University School of Medicine (2) · Unity Health Toronto (2)

What is being tested here

Drugs under test in Epistaxis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pazopanib112
Topical Sirolimus101
Ascorbic Acid101
Hyaluronic Acid101
Petrolatum101
Orange101
Nintedanib101
Tranexamic Acid026
Bevacizumab015
FloSeal Matrix002

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open · Angiogenesis inhibitors 6

Coming up

1phase 3 study under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 10 Epistaxis studies recruiting now, 8 (80%) set no upper age limit and 2 (20%) stop at 75 or younger. 1 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (20%) take healthy volunteers.

Recruiting studies that take each age, of 10
AgeWomenMen
101 (10%)1 (10%)
1810 (100%)10 (100%)
3010 (100%)10 (100%)
4010 (100%)10 (100%)
5010 (100%)10 (100%)
659 (90%)9 (90%)
758 (80%)8 (80%)
858 (80%)8 (80%)

Across all 96 studies, recruiting or not: 28% stop at 75 or younger and 22% at 65; 20% take children; 0% are for women only and 0% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Epistaxis studies take

Of 24 interventional studies with no phase under Epistaxis, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo3–25 · 24 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 96. Browse all 96 → or search them.